Near East University, Nicosia, Cyprus.
Istanbul University, İstanbul, Turkey.
Clin Nurs Res. 2022 Jul;31(6):1063-1071. doi: 10.1177/10547738211052387. Epub 2021 Oct 13.
This study was carried out to determine the effect of treatment on quality of life, symptoms, and social life in patients with gynecologic cancer. Data were collected through face-to-face interviews to evaluate the individual and disease characteristics of the patients. The Edmonton Symptom Assessment Scale was used to determine the severity of the side effects. Functional Assessment of Cancer Therapy-General 4 was used to evaluate the quality of life. The total post-treatment quality of life scores of the patients were lower than their total pre-treatment scores. Patients who received chemotherapy and chemoradiotherapy had a lower quality of life than those who received radiotherapy, and they were less involved in social activities. Half of the individuals participated in social activities in the pre-treatment period, but this rate decreased to 16.4% after the treatment started. In this study, the quality-of-life scores of the patients who received gynecologic cancer treatment decreased after treatment and the patients experienced many symptoms at an increasingly severe level.
本研究旨在确定治疗对妇科癌症患者生活质量、症状和社会生活的影响。通过面对面访谈收集数据，以评估患者的个体和疾病特征。使用埃德蒙顿症状评估量表来确定副作用的严重程度。使用癌症治疗功能评估-一般 4 来评估生活质量。患者的总治疗后生活质量评分低于总治疗前评分。接受化疗和放化疗的患者比接受放疗的患者生活质量更低，并且他们参与社会活动的程度较低。一半的个体在治疗前参与社会活动，但治疗开始后这一比例下降到 16.4%。在这项研究中，接受妇科癌症治疗的患者的生活质量评分在治疗后下降，并且患者经历了许多症状，且程度逐渐加重。
